Regencell looks like a rather speculative bet, and investors should look elsewhere, for instance, toward a well-established ...

Detailed price information for Regencell Bioscience Holdings Ltd (RGC-Q) from The Globe and Mail including charting and ...

Detailed price information for Regencell Bioscience Holdings Ltd (RGC-Q) from The Globe and Mail including charting and ...

Regencell Bioscience remains severely overvalued at a $6 billion market cap, despite having no revenue, assets, or business activity. RGC's 20-F filing revealed three material weaknesses in internal ...

Regencell Bioscience looks like a risky bet. It's generated zero revenue for several years in a row. Also, its valuation seems way out of line. 10 stocks we like better than Regencell Bioscience › ...

Regencell Bioscience Holdings Limited has surged 23,745% in 2025, reaching a $12b market cap despite having zero revenue. RGC's explosive upside is driven by float mechanics, with the founder and his ...

For more than three decades, investors have consistently had a next-big-thing technology or trend to captivate their attention and wallets. For instance, artificial intelligence (AI) has been a ...

Regencell Bioscience Holdings (NasdaqCM:RGC) is under investigation by the U.S. Department of Justice over trading in its ...

Regencell Bioscience Holdings Limited (NASDAQ:RGC) is one of the 12 Best Performing Stocks in the Last 6 Months. On June 17, Regencell Bioscience Holdings Limited (NASDAQ:RGC) announced that it had ...

Regencell Bioscience's outrageous performance in the past year is baffling. Despite the stock's sharp rise, there is little to look forward to for the drugmaker. Pfizer is a much better bet with its ...

Shares of Regencell Bioscience Holdings (NASDAQ: RGC) have been on quite a ride since their 2021 initial public offering (IPO), surging 9,800% year to date (as of Nov. 19). That's enough to drive many ...

Excitement surrounding stock splits in influential businesses has been a driving force for Wall Street's major stock indexes. A phenomenal company that's spent more than $26 billion to retire ...